Substrate Reduction Therapy (SRT) is a pharmacological treatment designed to reduce the accumulation of toxic substrates that contribute to the pathogenesis of certain genetic disorders. This approach is particularly relevant for conditions where enzyme deficiencies lead to the build-up of harmful substances, such as in lysosomal storage disorders.
